ACSL3 and cholangiocarcinoma: These findings are consistent with a general augmentation of ACSL3 levels in hepatic malignancies but clearly limit the usefulness of ACLS3 as an independent immunohistochemical marker for identifying HCC, although the differentiation of HCC from CCA was good.